(Q30652020)

25 June 2017

title

Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs (English)

1 reference

25 June 2017

1 reference

Hinke SA

1

1 reference

25 June 2017

Pospisilik JA

2

1 reference

25 June 2017

Demuth HU

3

1 reference

25 June 2017

Mannhart S

4

1 reference

25 June 2017

Kühn-Wache K

5

1 reference

25 June 2017

Hoffmann T

6

1 reference

25 June 2017

Nishimura E

7

1 reference

25 June 2017

Pederson RA

8

1 reference

25 June 2017

McIntosh CH

9

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Journal of Biological Chemistry

25 June 2017

published in

1 reference

25 June 2017

volume

275

1 reference

25 June 2017

issue

6

1 reference

25 June 2017

page(s)

3827-3834

1 reference

Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Proline-dependent structural and biological properties of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

GPCRDB: an information system for G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Glucagon.glucagon-like peptide I receptor chimeras reveal domains that determine specificity of glucagon binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Expression and signal transduction of the glucagon receptor in betaTC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Constitutive activity of glucagon receptor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Identification of an essential serine residue in glucagon: implication for an active site triad

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.6.3827

21 January 2018

Identifiers

DOI

10.1074/JBC.275.6.3827

1 reference

25 June 2017

1 reference